# AGED Diagnostics Liver Disease Assessment

> **NCT06348563** · EARLY_PHASE1 · UNKNOWN · sponsor: **Active Genomes Expressed Diagnostics, Corp** · enrollment: 400 (estimated)

## Conditions studied

- NASH With Fibrosis
- NAFLD
- Healthy

## Interventions

- **DIAGNOSTIC_TEST:** AGED Multiple Target Assay in Healthy Controls
- **DIAGNOSTIC_TEST:** AGED Multiple Target Assay in NAFLD Participants
- **DIAGNOSTIC_TEST:** AGED Multiple Target Assay in Fibrosis Participants

## Key facts

- **NCT ID:** NCT06348563
- **Lead sponsor:** Active Genomes Expressed Diagnostics, Corp
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-05-15
- **Primary completion:** 2025-05-15
- **Final completion:** 2025-09-15
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2024-04-04

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06348563

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06348563, "AGED Diagnostics Liver Disease Assessment". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06348563. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*